RALEIGH, N.C. – Qualyst is gearing up to add staff and space following its decision to offer a drug testing product in the form of a kit.
Qualyst, which employs 14 people, utilizes technology licensed from the University of North Carolina. It tracks absorption, distribution, metabolism, excretion and toxicology, or ADMET, in the body.
The company, which is privately held, has several international drug company clients.
The new kits will include B-CLEAR, an ADMET product that can help drug companies track reactions to drugs.
Qualyst plans to add 10 or more workers and seek additional space beyond the 6,000 square feet it now operates out of near the RBC Center in Raleigh, according to Ian Mehr, the company’s vice president for business development.